Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Purmx Logo
Purmx Growth Score
74
CB Rank
403609
Heat Score
43
Purmx is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.
Founded
obfuscation
PrivateSeries A Hiroshima, Hiroshima, Japan1-10 www.purmx.com/
Alternative Medicine
Biopharma
Biotechnology
Medical
Pharmaceutical
Overview

Purmx
Growth Score
74
Heat Score
43

Growth Score74
-7 pts
in past quarter
Heat Score 43
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Purmx

CB Rank
403609
Purmx is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.
Founded
obfuscation
PrivateSeries A Hiroshima, Hiroshima, Japan1-10 www.purmx.com/
Alternative Medicine
Biopharma
Biotechnology
Medical
Pharmaceutical

Funding Rounds

Series A
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Purmx Therapeutics Co., Ltd.
Also Known As Purmx Therapeutics
Operating Status Active
Company Type For Profit
Founders  Hidetoshi Tahara
About the Company
Purmx is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.
Phone Number +81 50-8892-0260
Contact Email info@mirx.jp
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

MIRX002
A microRNA-based nucleic acid medicine under clinical development for treating malignant pleural mesothelioma and head and neck cancer.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Purmx Logo
Series A - Purmx
1
obfuscation
Keio Innovation InitiativeSeries A
obfuscation
Series A - Purmx Logo
Series A - Purmx
1
obfuscation
Keio Innovation InitiativeSeries A
obfuscation
Series A - Purmx Logo
Series A - Purmx
1
obfuscation
Keio Innovation InitiativeSeries A
obfuscation
Series A - Purmx Logo
Series A - Purmx
1
obfuscation
Keio Innovation InitiativeSeries A
obfuscation
Series A - Purmx Logo
Series A - Purmx
1
obfuscation
Keio Innovation InitiativeSeries A

Funding Rounds

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Purmx Logo
Series A - Purmx
1
obfuscation
Keio Innovation InitiativeSeries A
obfuscation
Series A - Purmx Logo
Series A - Purmx
1
obfuscation
Keio Innovation InitiativeSeries A
obfuscation
Series A - Purmx Logo
Series A - Purmx
1
obfuscation
Keio Innovation InitiativeSeries A
obfuscation
Series A - Purmx Logo
Series A - Purmx
1
obfuscation
Keio Innovation InitiativeSeries A
obfuscation
Series A - Purmx Logo
Series A - Purmx
1
obfuscation
Keio Innovation InitiativeSeries A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

120

Active Website Tech Count

4Purmx is actively using 4 technologies for its website, according to BuiltWith. These include DNSSEC, CommonCrawl Top 5m, and  Visa.

Total IP

6The intellectual property of Purmx includes 4 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery. Additionally, Purmx has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Purmx's headquarters? Purmx is located in Hiroshima, Hiroshima, Japan.Who invested in Purmx? Purmx has 2 investors including Keio Innovation Initiative and  Yokohama Capital.When was the last funding round for Purmx? Purmx closed its last funding round on
obfuscation
from a Series A round.Who are Purmx's competitors? Alternatives and possible competitors to Purmx may include Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, and  Replimune Group.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|